Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as new therapeutic candidates against urease positive microorganisms: design, synthesis, pharmacological evaluations, and in silico studies.
Khalili Ghomi M, Noori M, Nazari Montazer M, Zomorodian K, Dastyafteh N, Yazdanpanah S, Sayahi MH, Javanshir S, Nouri A, Asadi M, Badali H, Larijani B, Irajie C, Iraji A, Mahdavi M. Khalili Ghomi M, et al. Among authors: javanshir s. Sci Rep. 2023 Jun 22;13(1):10136. doi: 10.1038/s41598-023-37203-z. Sci Rep. 2023. PMID: 37349372 Free PMC article.
New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α-glucosidase enzymes.
Mohammadi-Khanaposhtani M, Nori M, Valizadeh Y, Javanshir S, Dastyafteh N, Moaazam A, Hosseini S, Larijani B, Adibi H, Biglar M, Hamedifar H, Mahdavi M, Kamci H, Karakus A, Taslimi P. Mohammadi-Khanaposhtani M, et al. Among authors: javanshir s. Arch Pharm (Weinheim). 2022 May;355(5):e2100313. doi: 10.1002/ardp.202100313. Epub 2022 Feb 8. Arch Pharm (Weinheim). 2022. PMID: 35132681
New thioxothiazolidinyl-acetamides derivatives as potent urease inhibitors: design, synthesis, in vitro inhibition, and molecular dynamic simulation.
Dastyafteh N, Noori M, Nazari Montazer M, Zomorodian K, Yazdanpanah S, Iraji A, Khalili Ghomi M, Javanshir S, Asadi M, Dianatpour M, Biglar M, Larijani B, Amanlou M, Mahdavi M. Dastyafteh N, et al. Among authors: javanshir s. Sci Rep. 2023 Jan 2;13(1):21. doi: 10.1038/s41598-022-27234-3. Sci Rep. 2023. PMID: 36593349 Free PMC article.
Synthesis, in vitro inhibitor screening, structure-activity relationship, and molecular dynamic simulation studies of novel thioquinoline derivatives as potent α-glucosidase inhibitors.
Forozan R, Ghomi MK, Iraji A, Montazer MN, Noori M, Dastyafteh N, Mojtabavi S, Faramarzi MA, Sadat-Ebrahimi SE, Larijani B, Javanshir S, Mahdavi M. Forozan R, et al. Among authors: javanshir s. Sci Rep. 2023 May 15;13(1):7819. doi: 10.1038/s41598-023-35140-5. Sci Rep. 2023. PMID: 37188744 Free PMC article.
Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline-quinazolinone-thioacetamides.
Safapoor S, Halimi M, Ghomi MK, Noori M, Dastyafteh N, Javanshir S, Hosseini S, Mojtabavi S, Faramarzi MA, Nasli-Esfahani E, Larijani B, Fakhrioliaei A, Dekamin MG, Mohammadi-Khanaposhtani M, Mahdavi M. Safapoor S, et al. Among authors: javanshir s. RSC Adv. 2023 Jun 26;13(28):19243-19256. doi: 10.1039/d3ra01790g. eCollection 2023 Jun 22. RSC Adv. 2023. PMID: 37377867 Free PMC article.
Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3β level targeting Alzheimer's disease.
Noori M, Dastyafteh N, Safapoor S, Khalili Ghomi M, Tanideh R, Zomorodian K, Hamedifar H, Dara M, Zare S, Irajie C, Javanshir S, Rastegar H, Panahi N, Larijani B, Mahdavi M, Hajimiri MH, Iraji A. Noori M, et al. Among authors: javanshir s. Int J Biol Macromol. 2023 Dec 31;253(Pt 7):127392. doi: 10.1016/j.ijbiomac.2023.127392. Epub 2023 Oct 11. Int J Biol Macromol. 2023. PMID: 37827412
67 results